S. Gandhi, R. K. Tekade, and M. B. Chougule, Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances, Journal of Controlled Release, vol.194, pp.238-256, 2014.
DOI : 10.1016/j.jconrel.2014.09.001

C. Lippert, Chemistry and Biochemistry of a Leeding Anticancer Drug, 1999.

S. J. Dhar and . Lippard, Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate, Proceedings of the National Academy of Sciences, vol.8, issue.7, pp.22199-22204, 2009.
DOI : 10.1007/s00775-003-0471-6

P. J. Zhang and . Sadler, Advances in the design of organometallic anticancer complexes, Journal of Organometallic Chemistry, vol.839, pp.5-14, 2017.
DOI : 10.1016/j.jorganchem.2017.03.038

P. E. Barry and P. J. Sadler, Exploration of the medical periodic table: towards new targets, Chemical Communications, vol.48, issue.45, pp.5106-5131, 2013.
DOI : 10.1097/RLI.0b013e31828234d0

I. Gasser, N. Ott, and . Metzler-nolte, Organometallic Anticancer Compounds, Journal of Medicinal Chemistry, vol.54, issue.1, pp.3-25, 2011.
DOI : 10.1021/jm100020w
URL : https://doi.org/10.1021/jm100020w

S. E. Brabec, R. A. Howson, R. M. Kaner, J. Lord, and R. M. Malina, Metallohelices with activity against cisplatin-resistant cancer cells; does the mechanism involve DNA binding?, Chemical Science, vol.67, issue.12, pp.4407-4416, 2013.
DOI : 10.1158/0008-5472.CAN-07-2235
URL : http://pubs.rsc.org/en/content/articlepdf/2013/sc/c3sc51731d

E. Dörr and . Meggers, Metal complexes as structural templates for targeting proteins, Current Opinion in Chemical Biology, vol.19, pp.76-81, 2014.
DOI : 10.1016/j.cbpa.2014.01.005

R. Oehninger, I. Rubbiani, and . Ott, N-Heterocyclic carbene metal complexes in medicinal chemistry, Dalton Trans., vol.38, issue.10, pp.3269-3284, 2013.
DOI : 10.3109/03639045.2011.589853

D. Mjos and C. Orvig, Metallodrugs in Medicinal Inorganic Chemistry, Chemical Reviews, vol.114, issue.8, pp.4540-4563, 2014.
DOI : 10.1021/cr400460s
URL : http://doi.org/10.1021/cr400460s

S. Braga and A. M. Silva, A New Age for Iron: Antitumoral Ferrocenes, Organometallics, vol.32, issue.20, pp.5626-5639, 2013.
DOI : 10.1021/om400446y

I. S. Amin, M. Chuckowree, G. J. Wang, S. J. Tizzard, J. Coles et al., Synthesis of Oxindole-Based Bioorganometallic Kinase Inhibitors Incorporating One or More Ferrocene Groups, Organometallics, vol.32, issue.20, pp.5818-5825, 2013.
DOI : 10.1021/om400359m

J. James, M. Neudoer?, P. Eissmann, A. Jesse, H. Prokop et al., Enantioselective Synthesis of Ferrocenyl Nucleoside Analogues with Apoptosis-Inducing Activity, Organic Letters, vol.8, issue.13, pp.2763-2766, 2006.
DOI : 10.1021/ol060868f

V. Nguyen, A. Sallustrau, J. Balzarini, M. R. Bedford, J. C. Eden et al., Organometallic Nucleoside Analogues with Ferrocenyl Linker Groups: Synthesis and Cancer Cell Line Studies, Journal of Medicinal Chemistry, vol.57, issue.13, pp.5817-5822, 2014.
DOI : 10.1021/jm500246h

R. Mooney, T. Tiedt, N. Maghoub, J. O-'donovan, B. Crown et al., -(6-Ferrocenyl-2-naphthoyl) Dipeptide Ethyl Esters: Novel Organometallic Anticancer Compounds, Journal of Medicinal Chemistry, vol.55, issue.11, pp.5455-5466, 2012.
DOI : 10.1021/jm3004027

B. Deepthi, R. Trivedi, L. Giribabu, P. Sujitha, and C. G. Kumar, Effect of amide-triazole linkers on the electrochemical and biological properties of ferrocene-carbohydrate conjugates, Dalton Trans., vol.690, issue.4, pp.1180-1190, 2013.
DOI : 10.1016/j.jorganchem.2005.07.007

F. Salas, C. Herrmann, J. F. Cawthray, C. Nimphius, A. Kenkel et al., Structural Characteristics of Chloroquine-Bridged Ferrocenophane Analogues of Ferroquine May Obviate Malaria Drug-Resistance Mechanisms, Journal of Medicinal Chemistry, vol.56, issue.4, pp.1596-1613, 2013.
DOI : 10.1021/jm301422h

R. B. Pulukkody, S. K. Chupik, S. Montalvo, N. Khan, S. Bhuvanesh et al., Toward biocompatible dinitrosyl iron complexes: sugar-appended thiolates, Chem. Commun., vol.280, issue.6, pp.1180-1183, 2017.
DOI : 10.1074/jbc.M507916200

E. Messina, O. Labbe, E. A. Buriez, A. Hillard, D. Vessieres et al., Deciphering the Activation Sequence of Ferrociphenol Anticancer Drug Candidates, Chemistry - A European Journal, vol.28, issue.21, pp.6581-6587, 2012.
DOI : 10.1021/bi00429a028

A. Jaouen, S. Vessieres, and . Top, Ferrocifen type anti cancer drugs, Chemical Society Reviews, vol.54, issue.24, pp.8802-8817, 2015.
DOI : 10.1002/anie.201503048
URL : https://hal.archives-ouvertes.fr/hal-01221048

A. Top, G. Vessieres, J. Leclercq, J. Quivy, J. Tang et al., Synthesis, Biochemical Properties and Molecular Modelling Studies of Organometallic Specific Estrogen Receptor Modulators (SERMs), the Ferrocifens and Hydroxyferrocifens: Evidence for an Antiproliferative Effect of Hydroxyferrocifens on both Hormone-Dependent and Hormone-Independent Breast Cancer Cell Lines, Chemistry - A European Journal, vol.9, issue.21, pp.5223-5236, 2003.
DOI : 10.1002/chem.200305024

S. Jaouen and . Top, Advances in Organometallic Chemistry and Catalysis: The Silver, pp.563-580, 2014.

C. Vessieres, J. M. Corbet, N. Heldt, N. Lories, I. Jouy et al., A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines, Journal of Inorganic Biochemistry, vol.104, issue.5, pp.503-511, 2010.
DOI : 10.1016/j.jinorgbio.2009.12.020

A. Citta, A. Folda, P. Bindoli, S. Pigeon, A. Top et al., Evidence for Targeting Thioredoxin Reductases with Ferrocenyl Quinone Methides. A Possible Molecular Basis for the Antiproliferative Effect of Hydroxyferrocifens on Cancer Cells, Journal of Medicinal Chemistry, vol.57, issue.21, pp.8849-8859, 2014.
DOI : 10.1021/jm5013165
URL : https://hal.archives-ouvertes.fr/hal-01230376

M. Wang, S. Richard, P. M. Top, P. Dansette, A. Pigeon et al., Ferrocenyl Quinone Methide-Thiol Adducts as New Antiproliferative Agents: Synthesis, Metabolic Formation from Ferrociphenols, and Oxidative Transformation, Angewandte Chemie International Edition, vol.13, issue.35, pp.10431-10434, 2016.
DOI : 10.1021/tx990145n
URL : https://hal.archives-ouvertes.fr/hal-01345781

P. M. Hamels, E. A. Dansette, S. Hillard, A. Top, P. Vessieres et al., Ferrocenyl Quinone Methides as Strong Antiproliferative Agents: Formation by Metabolic and Chemical Oxidation of Ferrocenyl Phenols, Angewandte Chemie International Edition, vol.36, issue.48, pp.9124-9126, 2009.
DOI : 10.1039/b705030e

G. Michard, A. Jaouen, B. A. Vessieres, and . Bernard, Evaluation of cytotoxic properties of organometallic ferrocifens on melanocytes, primary and metastatic melanoma cell lines, Journal of Inorganic Biochemistry, vol.102, issue.11, pp.1980-1985, 2008.
DOI : 10.1016/j.jinorgbio.2008.07.014

C. Allard, E. Passirani, P. Garcion, A. Pigeon, G. Vessì-eres et al., Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, Journal of Controlled Release, vol.130, issue.2, pp.146-153, 2008.
DOI : 10.1016/j.jconrel.2008.05.027
URL : https://hal.archives-ouvertes.fr/inserm-00343557

E. Allard, D. Jarnet, A. Vessieres, S. Vinchon-petit, G. Jaouen et al., Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft, Pharmaceutical Research, vol.10, issue.1, pp.56-64, 2011.
DOI : 10.1093/infdis/137.2.122

L. Laine, E. Adriaenssens, A. Vessieres, G. Jaouen, C. Corbet et al., The in??vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer, Biomaterials, vol.34, issue.28, pp.6949-6956, 2013.
DOI : 10.1016/j.biomaterials.2013.05.065
URL : https://hal.archives-ouvertes.fr/hal-01230382

L. Laine, A. Clavreul, A. Rousseau, C. Tétaud, A. Vessieres et al., Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules, Nanomedicine: Nanotechnology, Biology and Medicine, vol.10, issue.8, pp.1667-1677, 2014.
DOI : 10.1016/j.nano.2014.05.002
URL : https://hal.archives-ouvertes.fr/hal-01624361

P. Wang, S. Pigeon, M. J. Top, G. Mcglinchey, and . Jaouen, Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides, Angewandte Chemie International Edition, vol.31, issue.35, pp.10230-10233, 2015.
DOI : 10.1021/om300382h
URL : https://hal.archives-ouvertes.fr/hal-01230371

H. Shoemaker, The NCI60 human tumour cell line anticancer drug screen, Nature Reviews Cancer, vol.98, issue.10, pp.813-823, 2006.
DOI : 10.4161/cbt.4.4.1616

G. Gut, P. D. Wood, and R. W. Redmond, Interaction of Triplet Photosensitizers with Nucleotides and DNA in Aqueous Solution at Room Temperature, Journal of the American Chemical Society, vol.118, issue.10, pp.2366-2373, 1996.
DOI : 10.1021/ja9519344

A. Scalcon, A. Citta, A. Folda, M. Bindoli, I. Salmain et al., Enzymatic oxidation of ansa-ferrocifen leads to strong and selective thioredoxin reductase inhibition in vitro, Journal of Inorganic Biochemistry, vol.165, pp.146-151, 2016.
DOI : 10.1016/j.jinorgbio.2016.08.005
URL : https://hal.archives-ouvertes.fr/hal-01401089

S. J. Wang and . Lippard, Cellular processing of platinum anticancer drugs, Nature Reviews Drug Discovery, vol.11, issue.4, pp.307-320, 2005.
DOI : 10.1016/0006-2952(88)90325-5

L. Romero-canelon, P. J. Salassa, and . Sadler, The Contrasting Activity of Iodido versus Chlorido Ruthenium and Osmium Arene Azo- and Imino-pyridine Anticancer Complexes: Control of Cell Selectivity, Cross-Resistance, p53 Dependence, and Apoptosis Pathway, Journal of Medicinal Chemistry, vol.56, issue.3, pp.1291-1300, 2013.
DOI : 10.1021/jm3017442

P. Görmen, S. Pigeon, E. A. Top, M. Hillard, C. G. Huché et al., Synthesis, Cytotoxicity, and COMPARE Analysis of Ferrocene and [3]Ferrocenophane Tetrasubstituted Olefin Derivatives against Human Cancer Cells, ChemMedChem, vol.693, issue.639, pp.2039-2050, 2010.
DOI : 10.1002/cmdc.201000286

T. Cohen and F. J. Mcgovern, Renal-Cell Carcinoma, New England Journal of Medicine, vol.353, issue.23, pp.2477-2490, 2005.
DOI : 10.1056/NEJMra043172

T. Bellamy, P-Glycoproteins and Multidrug Resistance, Annual Review of Pharmacology and Toxicology, vol.36, issue.1, pp.161-183, 1996.
DOI : 10.1146/annurev.pa.36.040196.001113